SBC Medical Group (NASDAQ:SBC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of SBC Medical Group (NASDAQ:SBC) from a buy rating to a strong-buy rating in a report released on Monday,Wall Street Zen reports.

Several other research analysts also recently commented on the company. BTIG Research reiterated a “buy” rating and set a $8.00 target price on shares of SBC Medical Group in a research note on Thursday, August 13th. Weiss Ratings upgraded shares of SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, September 22nd. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $8.50.

SBC Medical Group Stock Performance

NASDAQ SBC opened at $5.34 on Monday. The firm has a market capitalization of $549.22 million, a P/E ratio of 11.36, a price-to-earnings-growth ratio of 2.40 and a beta of 0.56. The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09. The firm’s fifty day moving average price is $4.17 and its two-hundred day moving average price is $3.65. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.51.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The firm had revenue of $49.19 million during the quarter, compared to the consensus estimate of $45.37 million. As a group, research analysts anticipate that SBC Medical Group will post 0.44 EPS for the current year.

Institutional Investors Weigh In On SBC Medical Group

Institutional investors have recently modified their holdings of the business. State Street Corp raised its stake in SBC Medical Group by 59.7% in the 2nd quarter. State Street Corp now owns 49,239 shares of the company’s stock worth $152,000 after purchasing an additional 18,400 shares in the last quarter. Citadel Advisors LLC acquired a new stake in shares of SBC Medical Group in the second quarter valued at approximately $446,000. Two Sigma Securities LLC bought a new stake in shares of SBC Medical Group in the second quarter valued at approximately $66,000. Bank of America Corp DE acquired a new stake in SBC Medical Group during the second quarter worth approximately $35,000. Finally, BlackRock Inc. bought a new position in SBC Medical Group during the 2nd quarter worth $2,846,000. Institutional investors own 60.82% of the company’s stock.

About SBC Medical Group

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.